Publication & Citation Trends
Publications
887 total
Small-cell lung cancer: what we know, what we need to know and the path forward
Cited by 911
OpenAlex
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Cited by 1,728
OpenAlex
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer PDF
Cited by 702
OpenAlex
Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer PDF
Cited by 1,568
OpenAlex
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy PDF
Cited by 2,428
OpenAlex
Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis
Cited by 1,484
OpenAlex
Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial
Cited by 1,127
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(389)
Lung Cancer Research Studies
(214)
Lung Cancer Diagnosis and Treatment
(126)
Cancer Genomics and Diagnostics
(77)
Neuroendocrine Tumor Research Advances
(73)
Affiliations
AstraZeneca (United Kingdom)
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
Griffith University
Hebron University